Transce3nd »

Mereo Biopharma Group Plc ads shares owned by Transce3nd

Quarter-by-quarter ownership of Mereo Biopharma Group Plc ads (MREO) shares owned by Transce3nd from 13F filings

Historical chart of Transce3nd investment in Mereo Biopharma Group Plc ads

Tip: Access up to 7 years of quarterly data

All positions including Mereo Biopharma Group Plc ads held by Transce3nd consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mereo Biopharma Group Plc ads by Transce3nd

Quarter filed Position value Share count Share price at filing
2025-06-30 $344 127 2.71
2025-03-31 $286 127 2.25
2024-12-31 $444 127 3.50

More positions owned by Transce3nd

Spdr S&p 500 Etf Tr Tr Unit Etf (SPY)
State Street Spdr Portfolio S&p 500 Etf Etf (SPLG)
Weitz Core Plus Income Fund Inst'l Class M (WCPBX)
Cibus C (CBUS)
Vanguard Federal Money Mkt Fund Investor Class MM (VMFXX)
Fullerthaler Behavioral Small-mid Core Equity Fd Inst'l Class M (FTSIX)
Vanguard Total Stock Market Vipers Etf (VTI)
St Spdr S&p Wld Xus Etf (SPDW)
Regan Capital Total Return Income Fund Institutional Class M (RCIRX)
Aqr Long-short Equity Fund Class I M (QLEIX)
River Canyon Total Return Bond Fund Inst'l Class M (RCTIX)
Oakmark Oakmark Fund Inst'l Class M (OANMX)
Blackrock Systematic Multi Strategy Fund Inst'l Class M (BIMBX)
Eaton Vance Global Macro Abs Ret Adv Fund Class I M (EGRIX)
J P Morgan Exchange-traded Etf (JEPI)

View all positions for Transce3nd

Top funds holding Mereo Biopharma Group Plc ads

Henderson Group
Rubric Capital Management
Frazier Life Sciences Management
Mangrove Partners
Standard Life Aberdeen
683 Capital Management
Rock Springs Capital Management
Clearline Capital
Alkeon Capital Management
Citadel Advisors
Goldman Sachs Group
Tejara Capital
Ubs Global Asset Management Americas
Schonfeld Strategic Advisors
Diadema Partners

View all funds holding Mereo Biopharma Group Plc ads